Mobile

CV Risk Reduction sub-study (Reduction in Recurrent Major CV disease)

Update Il y a 4 ans
Reference: EUCTR2012-003011-58

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To determine whether in patients with type 2 diabetes participating in the CANTOS main study, canakinumab compared to placebo, on top of standard of care increases insulin secretion and insulin sensitivity

Inclusion criteria

  • Atherosclerosis

Links